Insider Buy/Sell Details for the Biotechnology Industry — October 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (532)
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
53
Price
$43.54
Total Value
$2.31K
Shares Held After
390
% of Holdings
12.0%
IONIS PHARMACEUTICALS INC (IONS)
Devers Shannon L. — EVP, Chief Human Resources Ofc
Shares
1,357
Price
$43.54
Total Value
$59.08K
Shares Held After
17,811
% of Holdings
7.1%
Karyopharm Therapeutics Inc. (KPTI)
Abate Kristin — Chief Accounting Officer
Shares
4,788
Price
$0.34
Total Value
$1.65K
Shares Held After
18,616
% of Holdings
20.5%
X4 Pharmaceuticals, Inc (XFOR)
Craig Adam R — Director
Shares
4,600
Price
$2.58
Total Value
$11.88K
Shares Held After
333,251
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$543.85
Total Value
$21.75K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
391
Price
$542.67
Total Value
$212.19K
Shares Held After
324,483
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
169
Price
$541.62
Total Value
$91.53K
Shares Held After
324,874
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
239
Price
$539.60
Total Value
$128.96K
Shares Held After
325,043
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
401
Price
$538.55
Total Value
$215.96K
Shares Held After
325,282
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
760
Price
$537.74
Total Value
$408.68K
Shares Held After
325,683
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
865
Price
$536.66
Total Value
$464.21K
Shares Held After
326,443
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
535
Price
$535.67
Total Value
$286.58K
Shares Held After
327,308
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$534.41
Total Value
$342.02K
Shares Held After
327,843
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,818
Price
$533.32
Total Value
$969.58K
Shares Held After
328,483
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,378
Price
$532.46
Total Value
$1.27M
Shares Held After
330,301
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,024
Price
$531.54
Total Value
$544.30K
Shares Held After
332,679
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$530.48
Total Value
$127.31K
Shares Held After
333,703
% of Holdings
0.1%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
36,347
Price
$1.89
Total Value
$68.76K
Shares Held After
2,944,354
% of Holdings
1.2%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
25,000
Price
$23.98
Total Value
$599.60K
Shares Held After
1,047,205
% of Holdings
2.3%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
300
Price
$25.45
Total Value
$7.63K
Shares Held After
377,802
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
11,581
Price
$24.21
Total Value
$280.38K
Shares Held After
378,102
% of Holdings
3.0%
Septerna, Inc. (SEPN)
Bhatt Elizabeth — President and COO
Shares
2,906
Price
$37.61
Total Value
$109.31K
Shares Held After
174,209
% of Holdings
1.6%
Septerna, Inc. (SEPN)
Bhatt Elizabeth — President and COO
Shares
1,094
Price
$36.87
Total Value
$40.34K
Shares Held After
177,115
% of Holdings
0.6%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, Global Head of R&D
Shares
2,642
Price
$112.71
Total Value
$297.78K
Shares Held After
183,200
% of Holdings
1.4%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
4,728
Price
$26.93
Total Value
$127.33K
Shares Held After
35,207
% of Holdings
11.8%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
78,400
Price
$55.02
Total Value
$4.31M
Shares Held After
432,886
% of Holdings
15.3%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
37,270
Price
$54.20
Total Value
$2.02M
Shares Held After
511,286
% of Holdings
6.8%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
128,065
Price
$52.97
Total Value
$6.78M
Shares Held After
548,556
% of Holdings
18.9%
CG Oncology, Inc. (CGON)
POST LEONARD E — Director
Shares
500
Price
$62.48
Total Value
$31.24K
Shares Held After
0
% of Holdings
100.0%
CG Oncology, Inc. (CGON)
POST LEONARD E — Director
Shares
500
Price
$61.65
Total Value
$30.82K
Shares Held After
500
% of Holdings
50.0%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
7,066
Price
$15.27
Total Value
$107.90K
Shares Held After
89,229
% of Holdings
7.3%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
23,485
Price
$1.95
Total Value
$45.69K
Shares Held After
2,908,007
% of Holdings
0.8%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
25,000
Price
$23.57
Total Value
$589.15K
Shares Held After
1,047,205
% of Holdings
2.3%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
11,881
Price
$25.61
Total Value
$304.27K
Shares Held After
377,802
% of Holdings
3.0%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
300
Price
$116.30
Total Value
$34.89K
Shares Held After
1,054,543
% of Holdings
0.0%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
3,046
Price
$115.39
Total Value
$351.48K
Shares Held After
1,054,843
% of Holdings
0.3%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
6,654
Price
$114.48
Total Value
$761.72K
Shares Held After
1,057,889
% of Holdings
0.6%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
9,020
Price
$8.08
Total Value
$72.88K
Shares Held After
128,024
% of Holdings
6.6%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
15,355
Price
$8.08
Total Value
$124.07K
Shares Held After
296,906
% of Holdings
4.9%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
73,691
Price
$8.08
Total Value
$595.42K
Shares Held After
1,195,909
% of Holdings
5.8%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
11,513
Price
$8.08
Total Value
$93.03K
Shares Held After
198,597
% of Holdings
5.5%
MapLight Therapeutics, Inc. (MPLT)
Kreitzer Anatol — Chief Discovery Officer
Shares
12,248
Price
$7.84
Total Value
$96.02K
Shares Held After
168,678
% of Holdings
6.8%
MapLight Therapeutics, Inc. (MPLT)
GILLIS JONATHAN — CAO and Interim CFO
Shares
10,167
Price
$8.08
Total Value
$82.15K
Shares Held After
142,315
% of Holdings
6.7%
Moderna, Inc. (MRNA)
Hoge Stephen — President
Shares
39,145
Price
$220.72
Total Value
$8.64M
Shares Held After
1,636,565
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
719
Price
$546.56
Total Value
$392.98K
Shares Held After
45,172
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
2,615
Price
$545.69
Total Value
$1.43M
Shares Held After
45,891
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
791
Price
$544.85
Total Value
$430.98K
Shares Held After
48,506
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,983
Price
$543.56
Total Value
$1.08M
Shares Held After
49,297
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,924
Price
$542.49
Total Value
$1.04M
Shares Held After
51,280
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
268
Price
$541.64
Total Value
$145.16K
Shares Held After
53,204
% of Holdings
0.5%
532 transactions